ciprofloxacin has been researched along with vitamin k 3 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goswami, M; Jawali, N; Mangoli, SH | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chung, TT; Collin, F; Greive, SJ; Karkare, S; Lall, N; Maxwell, A; McKay, AR; Meyer, JJ; Mitchenall, LA | 1 |
3 other study(ies) available for ciprofloxacin and vitamin k 3
Article | Year |
---|---|
Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.
Topics: Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Catalase; Escherichia coli; Glutathione; Indicators and Reagents; Nitroblue Tetrazolium; Peroxidases; Peroxiredoxins; Reactive Oxygen Species; Streptomycin; Superoxide Dismutase | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action.
Topics: Adenosine Triphosphate; Anti-Infective Agents; Binding Sites; Catalytic Domain; DNA; DNA Gyrase; Escherichia coli; Humans; Inhibitory Concentration 50; Mass Spectrometry; Models, Chemical; Mycobacterium tuberculosis; Naphthoquinones; Protein Binding; Protein Structure, Tertiary; Staphylococcus aureus; Surface Plasmon Resonance; Tuberculosis | 2013 |